Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

Update Il y a 4 ans
Reference: NCT00335348

Woman and Man

  • | Country :
  • Australia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study has two main aims. The first is to assess whether Dexamethasone can increase the number of patients with who respond to Velcade. The second aim of this study is to see whether treating patients with relapsed multiple myeloma with Velcade and Dexamethasone for a longer period of time extends the time that the myeloma is under control.


Inclusion criteria

  • Multiple myeloma

Links